AI 路 DERM
Want to join a team of passionate people who want to build a future where no one dies from skin cancer?
馃憢 About us
We're an AI Health Tech company in the UK and Europe, leading from the front in the AI Diagnostics space.
Our AI Platform, DERM, is the UK鈥檚 and Europe鈥檚 first autonomous Class III AI as a medical device, certified to the same safety standard as a pacemaker. Independently proven to perform at least as well as a face-to-face dermatologist assessment, our technology is giving millions of people access to a fast and accurate way to detect skin cancer, saving significant time and costs for global healthcare systems and improving outcomes for patients. DERM has been an integrated part of NHS dermatology pathways for over six years and is already in use in 25 NHS Trusts, and trusted by private health providers including Bupa and Vitality. It has assessed over 300,000 patients and found more than 25,000 cancers, validated by histopathology, the diagnostic gold standard.
We are fast growing, raised 拢15M in series B funding in 2025, and are scaling across Europe - with regulatory approvals underway in other regions. In June 2026, we launched DERM Zero, the world' s first Class III regulated medical device technology to deliver autonomous clinical grade skin cancer assessments from a smartphone, changing the way that people can access clinically validated skin cancer checks.
If working for one of Time Magazine World鈥檚 Top Health Tech Companies appeals then we鈥檇 like to hear from you. We are hiring across science, technology, product, operations and commercial.